{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T04:21:58Z","timestamp":1787718118646,"version":"build-2784847793"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"DOI":"10.1007\/s10822-026-00909-z","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T04:12:57Z","timestamp":1787717577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Urea and carbamate-functionalized quinazolin-2,4-dione derivatives as EGFR tyrosine kinase inhibitors: synthesis, anticancer evaluation, molecular docking and molecular dynamics studies"],"prefix":"10.1007","volume":"40","author":[{"given":"Mohamed","family":"El-Naggar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawzy","family":"Abdelshafy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Mosallam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelfattah","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4616-0224","authenticated-orcid":false,"given":"Aboubakr H.","family":"Abdelmonsef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"issue":"4","key":"909_CR1","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3892\/ijo.2019.4704","volume":"54","author":"CC Lu","year":"2019","unstructured":"Lu CC, Chiang JH, Tsai FJ, Hsu YM, Juan YN, Yang JS, Chiu HY (2019) Metformin triggers the intrinsic apoptotic response in human AGS gastric adenocarcinoma cells by activating AMPK and suppressing MTOR\/AKT signalling. Int J Oncol 54(4):1271\u20131281. https:\/\/doi.org\/10.3892\/ijo.2019.4704","journal-title":"Int J Oncol"},{"key":"909_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ph15060700","author":"RM Abdelnaby","year":"2022","unstructured":"Abdelnaby RM, El-Malah AA, Fakhreldeen RR, Saeed MM, Nadeem RI, Younis NS, Abdel-Rahman HM, El-Dydamony NM (2022) In vitro anticancer activity screening of novel fused thiophene derivatives as VEGFR-2\/AKT dual inhibitors and apoptosis inducers. Pharmaceuticals (Basel). https:\/\/doi.org\/10.3390\/ph15060700","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"909_CR3","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3892\/ol.2017.6232","volume":"14","author":"W Lim","year":"2017","unstructured":"Lim W, Song G (2017) Inhibitory effects of delphinidin on the proliferation of ovarian cancer cells via PI3K\/AKT and ERK 1\/2 MAPK signal transduction. Oncol Lett 14(1):810\u2013818. https:\/\/doi.org\/10.3892\/ol.2017.6232","journal-title":"Oncol Lett"},{"issue":"1","key":"909_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/1735-5362.329923","volume":"17","author":"M Malekzadeh","year":"2022","unstructured":"Malekzadeh M, Dadkhah S, Khodarahmi G, Asadi P, Hassanzadeh F, Rostami M (2022) Some novel hybrid quinazoline-based heterocycles as potent cytotoxic agents. Res Pharm Sci 17(1):22\u201334. https:\/\/doi.org\/10.4103\/1735-5362.329923","journal-title":"Res Pharm Sci"},{"issue":"1","key":"909_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13065-019-0632-5","volume":"13","author":"AR Sayed","year":"2019","unstructured":"Sayed AR, Gomha SM, Abdelrazek FM, Farghaly MS, Hassan SA, Metz P (2019) Design, efficient synthesis and molecular docking of some novel Thiazolyl-Pyrazole derivatives as anticancer agents. BMC Chem 13(1):1\u201313. https:\/\/doi.org\/10.1186\/s13065-019-0632-5","journal-title":"BMC Chem"},{"key":"909_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-018-0204-3","author":"N Shindo","year":"2019","unstructured":"Shindo N, Fuchida H, Sato M, Watari K, Shibata T, Kuwata K, Miura C, Okamoto K, Hatsuyama Y, Tokunaga K, Sakamoto S, Morimoto S, Abe Y, Shiroishi M, Caaveiro JMM, Ueda T, Tamura T, Matsunaga N, Nakao T, Koyanagi S, Ohdo S, Yamaguchi Y, Hamachi I, Ono M, Ojida A (2019) Selective and reversible modification of kinase cysteines with chlorofluoroacetamides. Nat Chem Biol. https:\/\/doi.org\/10.1038\/s41589-018-0204-3","journal-title":"Nat Chem Biol"},{"issue":"2","key":"909_CR7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/biof.1784","volume":"48","author":"A Cruz-Gregorio","year":"2022","unstructured":"Cruz-Gregorio A, Aranda-Rivera AK, Pedraza-Chaverri J, Solano JD, Ibarra-Rubio ME (2022) Redox-sensitive signaling pathways in renal cell carcinoma. BioFactors 48(2):342\u2013358. https:\/\/doi.org\/10.1002\/biof.1784","journal-title":"BioFactors"},{"key":"909_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.saa.2017.04.070","volume":"184","author":"MO Almeida","year":"2017","unstructured":"Almeida MO, Barros DAS, Araujo SC, Faria SHDM, Maltarollo VG, Honorio KM (2017) Study on molecular structure, spectroscopic properties (FTIR and UV\u2013Vis), NBO, QTAIM, HOMO-LUMO energies and docking studies of 5-fluorouracil, a substance used to treat cancer. Spectrochim Acta A Mol Biomol Spectrosc 184:169\u2013176. https:\/\/doi.org\/10.1016\/j.saa.2017.04.070","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"issue":"1","key":"909_CR9","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.ygeno.2020.10.001","volume":"113","author":"R Singh","year":"2021","unstructured":"Singh R, Bhardwaj VK, Sharma J, Das P, Purohit R (2021) Discovery and in silico evaluation of aminoarylbenzosuberene molecules as novel checkpoint kinase 1 inhibitor determinants. Genomics 113(1):707\u2013715. https:\/\/doi.org\/10.1016\/j.ygeno.2020.10.001","journal-title":"Genomics"},{"key":"909_CR10","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2015.1039512","author":"S Ravez","year":"2011","unstructured":"Ravez S, Castillo-Aguilera O, Depreux P, Goossens L (2011) Quinazoline derivatives as anticancer drugs: a patent review (2011-present). Expert Opin Ther Pat. https:\/\/doi.org\/10.1517\/13543776.2015.1039512","journal-title":"Expert Opin Ther Pat"},{"issue":"8","key":"909_CR11","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","volume":"1773","author":"JA McCubrey","year":"2007","unstructured":"McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EWT, Chang F, Lehmann B, Terrian DM, Milella M, Tafuri A, Stivala F, Libra M, Basecke J, Evangelisti C, Martelli AM, Franklin RA (2007) Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta Mol Cell Res 1773(8):1263\u20131284. https:\/\/doi.org\/10.1016\/j.bbamcr.2006.10.001","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"909_CR12","doi-asserted-by":"publisher","first-page":"140720","DOI":"10.1016\/j.molstruc.2024.140720","volume":"1324","author":"AM Ahmed","year":"2025","unstructured":"Ahmed AM, Aboelez MO, Ezelarab HAA, Khodairy A, Hassan A, User MA, Salah H (2025) New S- and N-alkyl functionalized bis-1,2,4-triazolyl-based derivatives as potential dual EGFRWT and EGFRT790M inhibitors: synthesis, anti-proliferative evaluation, molecular docking study and ADMET studies. J Mol Struct 1324:140720. https:\/\/doi.org\/10.1016\/j.molstruc.2024.140720","journal-title":"J Mol Struct"},{"issue":"1","key":"909_CR13","doi-asserted-by":"publisher","first-page":"2199166","DOI":"10.1080\/14756366.2023.2199166","volume":"38","author":"H Kothayer","year":"2023","unstructured":"Kothayer H, Rezq S, Abdelkhalek AS, Romero DG, Elbaramawi SS (2023) Triple targeting of mutant EGFRL858R\/T790M, COX-2, and 15-LOX: design and synthesis of novel quinazolinone tethered phenyl urea derivatives for anti-inflammatory and anticancer evaluation. J Enzyme Inhib Med Chem 38(1):2199166. https:\/\/doi.org\/10.1080\/14756366.2023.2199166","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"2","key":"909_CR14","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3109\/14756360903169485","volume":"25","author":"A Garofalo","year":"2010","unstructured":"Garofalo A, Goossens L, Lemoine A, Farce A, Arlot Y, Depreux P (2010) Quinazoline-urea, new protein kinase inhibitors in treatment of prostate cancer. J Enzyme Inhib Med Chem 25(2):158\u2013171. https:\/\/doi.org\/10.3109\/14756360903169485","journal-title":"J Enzyme Inhib Med Chem"},{"key":"909_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21111572","author":"N Jiang","year":"2016","unstructured":"Jiang N, Bu Y, Wang Y, Nie M, Zhang D, Zhai X (2016) Design, synthesis and structure-activity relationships of novel diaryl urea derivatives as potential EGFR inhibitors. Molecules (Basel, Switzerland). https:\/\/doi.org\/10.3390\/molecules21111572","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"6","key":"909_CR16","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1039\/c3md00096f","volume":"4","author":"Q Zhang","year":"2013","unstructured":"Zhang Q, Diao Y, Wang F, Fu Y, Tang F, You Q, Zhou H (2013) Design and discovery of 4-anilinoquinazoline ureas as multikinase inhibitors targeting BRAF, VEGFR-2 and EGFR. Medchemcomm 4(6):979\u2013986. https:\/\/doi.org\/10.1039\/c3md00096f","journal-title":"Medchemcomm"},{"issue":"24","key":"909_CR17","doi-asserted-by":"publisher","first-page":"17158","DOI":"10.1039\/D4RA02960G","volume":"14","author":"AOA Ibrahim","year":"2024","unstructured":"Ibrahim AOA, Hassan A, Mosallam AM, Khodairy A, Rashdan HRM, Abdelmonsef AH (2024) New quinazolin-2,4-dione derivatives incorporating acylthiourea, pyrazole and\/or oxazole moieties as antibacterial agents via DNA gyrase inhibition. RSC Adv 14(24):17158\u201317169. https:\/\/doi.org\/10.1039\/D4RA02960G","journal-title":"RSC Adv"},{"issue":"2","key":"909_CR18","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1021\/acsomega.0c05116","volume":"6","author":"HR Rashdan","year":"2021","unstructured":"Rashdan HR, Shehadi IA, Abdelmonsef AH (2021) Synthesis, anticancer evaluation, computer-aided docking studies, and ADMET prediction of 1,2,3-triazolyl-pyridine hybrids as human aurora B kinase inhibitors. ACS Omega 6(2):1445\u20131455. https:\/\/doi.org\/10.1021\/acsomega.0c05116","journal-title":"ACS Omega"},{"key":"909_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fmolb.2020.00105","volume":"7","author":"A Haredi Abdelmonsef","year":"2020","unstructured":"Haredi Abdelmonsef A, Eldeeb Mohamed M, El-Naggar M, Temairk H, Mohamed Mosallam A (2020) Novel quinazolin-2,4-dione hybrid molecules as possible inhibitors against malaria: synthesis and in silico molecular docking studies. Front Mol Biosci 7:105. https:\/\/doi.org\/10.3389\/fmolb.2020.00105","journal-title":"Front Mol Biosci"},{"issue":"1","key":"909_CR20","doi-asserted-by":"publisher","first-page":"2189578","DOI":"10.1080\/14756366.2023.2189578","volume":"38","author":"A Hassan","year":"2023","unstructured":"Hassan A, Mubarak FAF, Shehadi IA, Mosallam AM, Temairk H, Badr M, Abdelmonsef AH (2023) Design and biological evaluation of 3-substituted quinazoline-2,4(1H,3H)-dione derivatives as dual c-Met\/VEGFR-2-TK inhibitors. J Enzyme Inhib Med Chem 38(1):2189578. https:\/\/doi.org\/10.1080\/14756366.2023.2189578","journal-title":"J Enzyme Inhib Med Chem"},{"key":"909_CR21","doi-asserted-by":"publisher","DOI":"10.21608\/ejchem.2024.305934.10053","author":"AH Abdelmonsef","year":"2024","unstructured":"Abdelmonsef AH, Abdelreheim M, Abdel Rady HS, Mohamed OA, Abdelhafiz I, Reffat HM (2024) Novel pyrazole-linked pyran hybrids: synthesis, anti-inflammatory evaluation, molecular docking studies. Egypt J Chem. https:\/\/doi.org\/10.21608\/ejchem.2024.305934.10053","journal-title":"Egypt J Chem"},{"key":"909_CR22","doi-asserted-by":"publisher","first-page":"106299","DOI":"10.1016\/j.bioorg.2022.106299","volume":"131","author":"AA Noser","year":"2023","unstructured":"Noser AA, Abdelmonsef AH, Salem MM (2023) Design, synthesis and molecular docking of novel substituted azepines as inhibitors of PI3K\/Akt\/TSC2\/MTOR signaling pathway in colorectal carcinoma. Bioorg Chem 131:106299. https:\/\/doi.org\/10.1016\/j.bioorg.2022.106299. (December 2022)","journal-title":"Bioorg Chem"},{"key":"909_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202504022","author":"AH Abdelmonsef","year":"2025","unstructured":"Abdelmonsef AH, Abdalla ER, Mosallam AM, Temairk H, Rashdan HRM, Alsoghier HM (2025) Antimicrobial potential of novel quinazolin\u20102,4\u2010dione derivatives bearing one and\/or two amide moieties: in vitro evaluation, molecular docking, and semiempirical calculations. ChemistrySelect. https:\/\/doi.org\/10.1002\/slct.202504022","journal-title":"ChemistrySelect"},{"issue":"12","key":"909_CR24","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1039\/C8OB00138C","volume":"16","author":"AK Ghosh","year":"2018","unstructured":"Ghosh AK, Sarkar A, Brindisi M (2018) The Curtius rearrangement: mechanistic insight and recent applications in natural product syntheses. Org Biomol Chem 16(12):2006\u20132027. https:\/\/doi.org\/10.1039\/C8OB00138C","journal-title":"Org Biomol Chem"},{"issue":"12","key":"909_CR25","doi-asserted-by":"publisher","first-page":"e627","DOI":"10.1002\/ctm2.627","volume":"11","author":"J Li","year":"2021","unstructured":"Li J, Zhang Y, Sun J, Chen L, Gou W, Chen C-W, Zhou Y, Li Z, Chan DW, Huang R, Pei H, Zheng W, Li Y, Xia M, Zhu W (2021) Discovery and characterization of potent And-1 inhibitors for cancer treatment. Clin Transl Med 11(12):e627. https:\/\/doi.org\/10.1002\/ctm2.627","journal-title":"Clin Transl Med"},{"issue":"1","key":"909_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1124\/mol.109.055855","volume":"76","author":"C Yan","year":"2009","unstructured":"Yan C, Shieh B, Reigan P, Zhang Z, Colucci MA, Chilloux A, Newsome JJ, Siegel D, Chan D, Moody CJ, Ross D (2009) Potent activity of indolequinones against human pancreatic cancer: identification of thioredoxin reductase as a potential target. Mol Pharmacol 76(1):163\u2013172. https:\/\/doi.org\/10.1124\/mol.109.055855","journal-title":"Mol Pharmacol"},{"issue":"3","key":"909_CR27","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/bab.2199","volume":"69","author":"F Tanveer","year":"2022","unstructured":"Tanveer F, Anwar MF, Siraj B, Zarina S (2022) Evaluation of anti-EGFR potential of quinazoline derivatives using molecular docking: an in silico approach. Biotechnol Appl Biochem 69(3):1226\u20131237. https:\/\/doi.org\/10.1002\/bab.2199","journal-title":"Biotechnol Appl Biochem"},{"issue":"9","key":"909_CR28","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.3390\/ph15091132","volume":"15","author":"AS Abouzied","year":"2022","unstructured":"Abouzied AS, Abd-Rabo MM, Huwaimel B, Almahmoud SA, Almarshdi AA, Alharbi FM, Alenzi SS, Albsher BN, Alafnan A (2022) In silico pharmacokinetic profiling of the identified bioactive metabolites of pergularia tomentosa L. Latex Extr..act and in vitro cytotoxic activity via the induction of caspase-dependent apoptosis with S-phase arrest. Pharmaceuticals (Basel) 15(9):1132. https:\/\/doi.org\/10.3390\/ph15091132","journal-title":"Pharmaceuticals (Basel)"},{"key":"909_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27030819","author":"T Amelia","year":"2022","unstructured":"Amelia T, Kartasasmita RE, Ohwada T, Tjahjono DH (2022) Structural insight and development of EGFR tyrosine kinase inhibitors. Molecules. https:\/\/doi.org\/10.3390\/molecules27030819","journal-title":"Molecules"},{"issue":"1","key":"909_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2946-1-15","volume":"1","author":"Z Bikadi","year":"2009","unstructured":"Bikadi Z, Hazai E (2009) Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock. J Cheminform 1(1):1\u201316. https:\/\/doi.org\/10.1186\/1758-2946-1-15","journal-title":"J Cheminform"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00909-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-026-00909-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-026-00909-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T04:12:58Z","timestamp":1787717578000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-026-00909-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["909"],"URL":"https:\/\/doi.org\/10.1007\/s10822-026-00909-z","relation":{},"ISSN":["1573-4951"],"issn-type":[{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"215"}}